Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Carbon Dots As a Potential Therapeutic Agent for Anemia Treatment in Malignancies

Yuanlin Xu, Boyang Wang, Huan Zhang, Xiaoli Qu, Mingming Zhang, Xiuli An, Siyu Lu, Shijie Zhang

Blood (2019) 134 (Supplement_1): 941.

https://doi.org/10.1182/blood-2019-130971

Published: 2019

Journal Articles

P38α/JNK Signaling Restrains Erythropoiesis By Suppressing Ezh2-Mediated Epigenetic Silencing of Bim

Ping Hu, MD PhD, Angel Nebreda, PhD, Helmut Hanenberg, MD, Garrett Kinnebrew, MD, Mircea Ivan, MD PhD, Mervin C. Yoder, MD, Marie-Dominique Filippi, PhD, Hal E. Broxmeyer, PhD, Reuben Kapur, PhD

Blood (2018) 132 (Supplement 1): 3837.

https://doi.org/10.1182/blood-2018-99-117098

Published: 2018

Journal Articles

TP-0184 Inhibits ALK2/ACVR1, Decreases Hepcidin Levels, and Demonstrates Activity in Preclinical Mouse Models of Functional Iron Deficiency

Peter Peterson, PhD, W K, Clifford Whatcott, PhD, Adam Siddiqui-Jain, PhD, Steven Weitman, MD PhD, Mark Kieran, MD PhD, David J. Bearss, PhD, Steven L. Warner, PhD

Blood (2017) 130 (Supplement 1): 937.

https://doi.org/10.1182/blood.V130.Suppl_1.937.937

Published: 2017

Journal Articles

Novel Series of ALK2 Inhibitors That Alter Hepcidin Expression As Potential Therapeutics for Anemia of Chronic Disease

Wontak Kim, Kyle S. Maughan, Katherine K. Soh, Jeremiah J. Bearss, Brigham L. Bahr, David J. Bearss, PhD, Steven L. Warner, PhD

Blood (2014) 124 (21): 212.

https://doi.org/10.1182/blood.V124.21.212.212

Published: 2014

Journal Articles

Iron Supplementation Adjunct to Erythropoiesis Stimulating Agents Is Cost Saving for Chemotherapy-Related Anemia in the Era of Biosimilars

Monia Marchetti, MD PhD, Giovanni Barosi, MD, Paolo Pedrazzoli

Blood (2014) 124 (21): 2165.

https://doi.org/10.1182/blood.V124.21.2165.2165

Published: 2014

Journal Articles

Autoimmune Hemolytic Anemia In Cancer Patients At a Tertiary Center In Southern Nigeria

Kaladada I. Korubo, MBBS, FMCPATH, Chijioke A. Nwauche, MBBS, FWACP, Oseikhuemen A. Ejele, MBBS, FWACP, FMCPATH

Blood (2013) 122 (21): 4658.

https://doi.org/10.1182/blood.V122.21.4658.4658

Published: 2013

Journal Articles

Serum Prohepcidin and Iron Homeostasis in Patients with Breast Cancer

Janet G. Grudeva, MD, PhD, Ivanka Slavejnova Nenova, Dora Dimitrova Terzieva, Maria Ivanova Spasova, Nikolay Petrov Boyadjiev

Blood (2011) 118 (21): 5291.

https://doi.org/10.1182/blood.V118.21.5291.5291

Published: 2011

Journal Articles

Cancer Related Anemia in the Developing World: Risk Factors and Treatment Patterns

George Kunnackal John, MBBS, Sirisha Sanamandra, MBBS, Arun S. Shet, MD

Blood (2011) 118 (21): 4747.

https://doi.org/10.1182/blood.V118.21.4747.4747

Published: 2011

Journal Articles

Two Mouse Models Illustrate Different Mechanisms of Anemia of Cancer

Airie Kim, M.D., Victoria Gabayan, Oliver Dorigo, M.D., Ph.D., Tomas Ganz, M.D., Ph.D., Seth Rivera, M.D., Ph.D.

Blood (2010) 116 (21): 2034.

https://doi.org/10.1182/blood.V116.21.2034.2034

Published: 2010

Journal Articles

Inhibition of Interleukin-6 (IL-6) Reverses Anemia In Patients with Advanced Non Small Cell Lung Cancer (NSCLC): Results of a Phase II, Randomized, Double-Blind, Placebo-Controlled Trial

Michael W. Schuster, MD, James R Rigas, MD, Sergey V Orlov, MD, Branislav Milovanovic, MD, Kumar Prabhash, Jeffrey T Smith, MD

Blood (2010) 116 (21): 640.

https://doi.org/10.1182/blood.V116.21.640.640

Published: 2010

Journal Articles

Siltuximab Treatment Increases Hemoglobin (Hb) Levels: Preliminary Results From a Prospective Phase 1 Study In Refractory Solid Tumors

R. Kurzrock, E. Angévin, S. Cohen, J. Van Laethem, B. Rijnbeek, J. Vermeulen, B. Tromp, W. Li, M. Reddy, M. Cornfeld, J. Tabernero

Blood (2010) 116 (21): 5150.

https://doi.org/10.1182/blood.V116.21.5150.5150

Published: 2010

Journal Articles

Determinants of Intracranial Hemorrhage Incidence in Patients on Oral Anticoagulation Followed at the Lahey Clinic.

Simon Mantha, MD, Ann M Pianka, ANP, MSN, Nicholas P Tsapatsaris, MD

Blood (2010) 116 (21): 1101.

https://doi.org/10.1182/blood.V116.21.1101.1101

Published: 2010

Journal Articles

Intravenous Iron Supplementation for the Treatment of Cancer-Related Anemia – Systematic Review and Meta-Analysis

Anat Gafter-Gvili, MD, Benaya Rozen-Zvi, MD, Liat Vidal, MD, Uzi Gafter, MD, PHD, Johan F. Vansteenkiste, MD, Ofer Shpilberg, MD, MPH

Blood (2010) 116 (21): 4249.

https://doi.org/10.1182/blood.V116.21.4249.4249

Published: 2010

Journal Articles

Development of a Sandwich ELISA to Detect Hepcidin in Human Serum.

Tara L Arvedson, Ph.D., George Doellgast, Ph.D., Hossein Salimi-Moosavi, Ph.D., Chadwick King, Ph.D., Ian Foltz, Ph.D., Ching Chen, Ph.D., Hongyan Li, Ph.D., Barbra J Sasu, PhD

Blood (2009) 114 (22): 2000.

https://doi.org/10.1182/blood.V114.22.2000.2000

Published: 2009

Journal Articles

Cancer Related Anemia in the Era of Erythropoietin Stimulating Agents (ESA)Uncertainty: A Single Cancer Institution Experience.

Hikmat Abdel-Razeq, MD, Shadi B Hijjawi, MD, Hazem Abdulelah, MD, Yousef Ismael, MD, Rula Amarin, MD, Majid Asawaeer, MD, Jamilah Shubeilat, MD, Haitham Shaheen, MD, Alaa Addasi, MD, Dalia Al-Rimawi, Luna Zaru, PhD

Blood (2009) 114 (22): 5085.

https://doi.org/10.1182/blood.V114.22.5085.5085

Published: 2009

Journal Articles

CNTO328 (Anti-IL-6 mAb) Treatment Is Associated with An Increase in Hemoglobin (Hb) and Decrease in Hepcidin Levels in Renal Cell Carcinoma (RCC).

Martin Schipperus, Britte Rijnbeek, Manjula Reddy, Xiang Qin, Mark J. Cornfeld

Blood (2009) 114 (22): 4045.

https://doi.org/10.1182/blood.V114.22.4045.4045

Published: 2009

Journal Articles

Comparison of the Management of Anemia in Patients with Solid Versus Hematological Malignancies Treated with Erythropoiesis Stimulating Agents (ESAs): Findings from the European Anemia Cancer Treatment (A.C.T.) Study

Heinz Ludwig, Matti Aapro, Carsten Bokemeyer, Pierre Soubeyran, Michael Muenzberg, Matthew Turner, Karen MacDonald, Tara Albrecht, Ivo Abraham

Blood (2008) 112 (11): 4715.

https://doi.org/10.1182/blood.V112.11.4715.4715

Published: 2008

Journal Articles

Erythropoietin and Cyclophosphamide Combined Treatment Additively Enhances Immunoglobulin Production in Mice

Lilach Lifshitz, MD/PhD, student, Assaf Berger, MD, Maayan Avneon, Msc, Moshe Mittelman, MD, Drorit Neumann, PhD

Blood (2008) 112 (11): 4913.

https://doi.org/10.1182/blood.V112.11.4913.4913

Published: 2008

Journal Articles

The Role of Hepcidin in Anemia of Cancer

Seth Rivera, MD, PhD, Airie Kim, MD, Tomas Ganz, MD, PhD

Blood (2008) 112 (11): 3835.

https://doi.org/10.1182/blood.V112.11.3835.3835

Published: 2008

Journal Articles

Investigation of Epoetin alfa (EPO) 80,000 Units (U) Every 4 Weeks (Q4W) vs. 40,000 U Every 2 Weeks (Q2W) in Patients with Cancer Not Receiving Chemotherapy (CT) or Radiation Therapy (RT): Final Results.

Daniel Shasha, MD, Fitzroy Dawkins, MD, Donghan Luo, PhD, Francois E. Wilhelm, MD, PhD, MSc, Marc Kamin, MD

Blood (2007) 110 (11): 3775.

https://doi.org/10.1182/blood.V110.11.3775.3775

Published: 2007

NARROW

Carbon Dots As a Potential Therapeutic Agent for Anemia Treatment in Malignancies

P38α/JNK Signaling Restrains Erythropoiesis By Suppressing Ezh2-Mediated Epigenetic Silencing of Bim

TP-0184 Inhibits ALK2/ACVR1, Decreases Hepcidin Levels, and Demonstrates Activity in Preclinical Mouse Models of Functional Iron Deficiency

Novel Series of ALK2 Inhibitors That Alter Hepcidin Expression As Potential Therapeutics for Anemia of Chronic Disease

Iron Supplementation Adjunct to Erythropoiesis Stimulating Agents Is Cost Saving for Chemotherapy-Related Anemia in the Era of Biosimilars

Autoimmune Hemolytic Anemia In Cancer Patients At a Tertiary Center In Southern Nigeria

Serum Prohepcidin and Iron Homeostasis in Patients with Breast Cancer

Cancer Related Anemia in the Developing World: Risk Factors and Treatment Patterns

Two Mouse Models Illustrate Different Mechanisms of Anemia of Cancer

Inhibition of Interleukin-6 (IL-6) Reverses Anemia In Patients with Advanced Non Small Cell Lung Cancer (NSCLC): Results of a Phase II, Randomized, Double-Blind, Placebo-Controlled Trial

Siltuximab Treatment Increases Hemoglobin (Hb) Levels: Preliminary Results From a Prospective Phase 1 Study In Refractory Solid Tumors

Determinants of Intracranial Hemorrhage Incidence in Patients on Oral Anticoagulation Followed at the Lahey Clinic.

Intravenous Iron Supplementation for the Treatment of Cancer-Related Anemia – Systematic Review and Meta-Analysis

Development of a Sandwich ELISA to Detect Hepcidin in Human Serum.

Cancer Related Anemia in the Era of Erythropoietin Stimulating Agents (ESA)Uncertainty: A Single Cancer Institution Experience.

CNTO328 (Anti-IL-6 mAb) Treatment Is Associated with An Increase in Hemoglobin (Hb) and Decrease in Hepcidin Levels in Renal Cell Carcinoma (RCC).

Comparison of the Management of Anemia in Patients with Solid Versus Hematological Malignancies Treated with Erythropoiesis Stimulating Agents (ESAs): Findings from the European Anemia Cancer Treatment (A.C.T.) Study

Erythropoietin and Cyclophosphamide Combined Treatment Additively Enhances Immunoglobulin Production in Mice

The Role of Hepcidin in Anemia of Cancer

Investigation of Epoetin alfa (EPO) 80,000 Units (U) Every 4 Weeks (Q4W) vs. 40,000 U Every 2 Weeks (Q2W) in Patients with Cancer Not Receiving Chemotherapy (CT) or Radiation Therapy (RT): Final Results.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only